Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway

Author:

Sun Xianchao1,Xin Shiyong1,Zhang Ying2,Jin Liang1,Liu Xiang1,Zhang Jiaxin1,Mei Wangli1,Zhang Bihui1,Ma Weiguo3,Ye Lin1

Affiliation:

1. Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, P.R. China

2. Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China

3. Department of Urology, Tongxin People's Hospital, Tongxin, Ningxia 751300, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference41 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. The prostate cancer landscape in Europe: Current challenges, future opportunities;Marhold;Cancer Lett,2022

3. Prostate cancer;Rebello;Nat Rev Dis Primers,2021

4. Prostate cancer and prostatic diseases best of asia, 2019: Challenges and opportunities;Zhu;Prostate Cancer Prostatic Dis,2020

5. LNCcation: lncRNA localization and function;Bridges;J Cell Biol,2021

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3